Global AAV Plasmid Market Growth (Status and Outlook) 2023-2029

Global AAV Plasmid Market Growth (Status and Outlook) 2023-2029

AAV plasmids (adeno-associated virus plasmids) are the primary viral vectors used in in vivo gene therapy clinical trials due to their high efficiency and enhanced safety in humans.

LPI (LP Information)' newest research report, the “AAV Plasmid Industry Forecast” looks at past sales and reviews total world AAV Plasmid sales in 2022, providing a comprehensive analysis by region and market sector of projected AAV Plasmid sales for 2023 through 2029. With AAV Plasmid sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AAV Plasmid industry.

This Insight Report provides a comprehensive analysis of the global AAV Plasmid landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on AAV Plasmid portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AAV Plasmid market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AAV Plasmid and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AAV Plasmid.

The global AAV Plasmid market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for AAV Plasmid is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for AAV Plasmid is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for AAV Plasmid is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key AAV Plasmid players cover PlasmidFactory GmbH, GeneCopoeia, Thermo Fisher Scientific, OriGene, Takara Bio, Azenta Life Sciences, Sartorius, Aldevron and Omega Bio Tek, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of AAV Plasmid market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
AAV Plasmids with C-terminal TGFP Tag
AAV Plasmid with C-terminal TRFP Tag

Segmentation by application
Laboratory
Hospital
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
PlasmidFactory GmbH
GeneCopoeia
Thermo Fisher Scientific
OriGene
Takara Bio
Azenta Life Sciences
Sartorius
Aldevron
Omega Bio Tek
Addgene
Viral Vector Core
Azenta
OXGENE

Please note: The report will take approximately 2 business days to prepare and deliver.